These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 21460407)

  • 21. Specificities of atrial electrophysiology: Clues to a better understanding of cardiac function and the mechanisms of arrhythmias.
    Hatem SN; Coulombe A; Balse E
    J Mol Cell Cardiol; 2010 Jan; 48(1):90-5. PubMed ID: 19744488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statins and polyunsaturated fatty acids for treatment of atrial fibrillation.
    Savelieva I; Camm J
    Nat Clin Pract Cardiovasc Med; 2008 Jan; 5(1):30-41. PubMed ID: 18094671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling.
    Mayyas F; Alzoubi KH; Van Wagoner DR
    Int J Cardiol; 2013 Oct; 168(6):5135-42. PubMed ID: 23993726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between renin-angiotensin-aldosterone system blockers and postoperative atrial fibrillation in patients with mild and moderate left ventricular dysfunction.
    Ozaydin M; Varol E; Türker Y; Peker O; Erdoğan D; Doğan A; Ibrişim E
    Anadolu Kardiyol Derg; 2010 Apr; 10(2):137-42. PubMed ID: 20382613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Upstream therapy of atrial fibrillation in patients with heart failure].
    Alboni P; Gianfranchi L; Pacchioni F
    G Ital Cardiol (Rome); 2009 Sep; 10(9):566-71. PubMed ID: 19891248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Non-channel drugs to prevent atrial fibrillation].
    Fazekas T; Liszkai G
    Orv Hetil; 2005 Nov; 146(45):2287-94. PubMed ID: 16304807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antifibrillatory agents and potassium channels in the atria: pore block versus channel trafficking.
    McEwen DP; Martens JR
    Mol Interv; 2009 Apr; 9(2):79-86. PubMed ID: 19401540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alcohol-induced electrical remodeling: effects of sustained short-term ethanol infusion on ion currents in rabbit atrium.
    Laszlo R; Eick C; Schwiebert M; Schreiner B; Weig HJ; Weretka S; Bosch RF; Schreieck J
    Alcohol Clin Exp Res; 2009 Oct; 33(10):1697-703. PubMed ID: 19572985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress.
    Korantzopoulos P; Kolettis T; Siogas K; Goudevenos J
    Med Sci Monit; 2003 Sep; 9(9):RA225-9. PubMed ID: 12960937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimizing the management of atrial fibrillation: focus on current guidelines and the impact of new agents on future recommendations.
    Naccarelli GV; Curtis AB
    J Cardiovasc Pharmacol Ther; 2010 Sep; 15(3):244-56. PubMed ID: 20562374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiarrhythmic therapy in atrial fibrillation.
    Ravens U
    Pharmacol Ther; 2010 Oct; 128(1):129-45. PubMed ID: 20624425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidative stress: a possible pathogenesis of atrial fibrillation.
    Huang CX; Liu Y; Xia WF; Tang YH; Huang H
    Med Hypotheses; 2009 Apr; 72(4):466-7. PubMed ID: 19103473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multiple ion channel blocker, NIP-142, for the treatment of atrial fibrillation.
    Tanaka H; Hashimoto N
    Cardiovasc Drug Rev; 2007; 25(4):342-56. PubMed ID: 18078434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aldosterone receptor antagonism in heart failure.
    Jennings DL; Kalus JS; O'Dell KM
    Pharmacotherapy; 2005 Aug; 25(8):1126-33. PubMed ID: 16207104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mineralocorticoid receptor and cardiac arrhythmia.
    Gravez B; Tarjus A; Jaisser F
    Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):910-5. PubMed ID: 23888997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin II receptor blockers in the prevention of atrial fibrillation.
    Barra S; Silvestri N; Vitagliano G; Madrid A; Gaeta G
    Expert Opin Pharmacother; 2009 Jun; 10(9):1395-411. PubMed ID: 19466911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of spironolactone on electrical and structural remodeling of atrium in congestive heart failure dogs.
    Yang SS; Han W; Zhou HY; Dong G; Wang BC; Huo H; Wei N; Cao Y; Zhou G; Xiu CH; Li WM
    Chin Med J (Engl); 2008 Jan; 121(1):38-42. PubMed ID: 18208664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between connexins and atrial activation during human atrial fibrillation.
    Kanagaratnam P; Cherian A; Stanbridge RD; Glenville B; Severs NJ; Peters NS
    J Cardiovasc Electrophysiol; 2004 Feb; 15(2):206-16. PubMed ID: 15028052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aldosterone-receptor antagonism as a potential therapeutic option for atrial fibrillation.
    Lendeckel U; Dobrev D; Goette A
    Br J Pharmacol; 2010 Apr; 159(8):1581-3. PubMed ID: 20388187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pathophysiology of the renin-angiotensin-system in atrial fibrillation].
    Heusch G; Schulz R
    Dtsch Med Wochenschr; 2006 Apr; 131(15):817-20. PubMed ID: 16607602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.